RNA, 7SL, cytoplasmic 286, pseudogene (RN7SL286P)

RN7SL286P (RNA, 7SL, cytoplasmic 286, pseudogene) is a **pseudogene** of the 7SL RNA family. Pseudogenes are typically non-functional copies of genes that arise through gene duplication or retrotransposition and accumulate mutations that disable protein or functional RNA production[5][6][7]. The genuine 7SL RNA is an essential non-coding RNA component of the **signal recognition particle** (SRP), which is central in directing nascent proteins to the endoplasmic reticulum during protein synthesis[1][3]. However, RN7SL286P is considered non-functional and does not encode for an active RNA molecule involved in this pathway[7][5][6]. Pseudogenes like RN7SL286P are generally not therapeutic targets, have no known interactions with drugs, and play no established direct biological or disease roles. Some pseudogenes can generate regulatory RNA fragments, but there is no evidence to date implicating RN7SL286P in such roles[8]. **Note:** The target is labeled as a pseudogene (RN7SL286P), is not a receptor or therapeutic target, and is not druggable or biologically functional as a canonical molecule. The principal name, functional description, and lack of biological or therapeutic significance all indicate that "RNA, 7SL, cytoplasmic 286, pseudogene" is not an actionable, canonical drug discovery target[7][5][6].

Other names

RN7SL286PRNA, 7SL, cytoplasmic 286, pseudogene